Unknown

Dataset Information

0

Extended Adjuvant Chemotherapy in Triple-Negative Breast Cancer.


ABSTRACT: Triple-negative breast cancer (TNBC) represents a heterogeneous breast cancer subtype with a poor prognosis. The optimal adjuvant chemotherapy regimen is still unknown. Although numerous large randomized trials have established the benefit of adjuvant anthracyclines and/or taxanes in TNBC, there is no preferred regimen for these patients. There is currently no guideline. Moreover, without knowing the optimal treatment backbone, it will not be possible to evaluate whether adding agents such as platinum or other novel therapies is beneficial for TNBC patients. Furthermore, the best duration of adjuvant treatment in TNBC is still unknown. This review will focus on results of clinical trials that analyzed the benefits of extending the duration of adjuvant treatment in TNBCs with maintenance treatments. We will further discuss promising results in favor of other new agents including capecitabine, metronomic treatment, and biological drugs.

SUBMITTER: Locatelli MA 

PROVIDER: S-EPMC5527164 | biostudies-other | 2017 Jul

REPOSITORIES: biostudies-other

altmetric image

Publications

Extended Adjuvant Chemotherapy in Triple-Negative Breast Cancer.

Locatelli Marzia A MA   Curigliano Giuseppe G   Eniu Alexandru A  

Breast care (Basel, Switzerland) 20170627 3


Triple-negative breast cancer (TNBC) represents a heterogeneous breast cancer subtype with a poor prognosis. The optimal adjuvant chemotherapy regimen is still unknown. Although numerous large randomized trials have established the benefit of adjuvant anthracyclines and/or taxanes in TNBC, there is no preferred regimen for these patients. There is currently no guideline. Moreover, without knowing the optimal treatment backbone, it will not be possible to evaluate whether adding agents such as pl  ...[more]

Similar Datasets

| S-EPMC5994186 | biostudies-literature
| S-EPMC3918886 | biostudies-literature
| S-EPMC3265248 | biostudies-literature
| S-EPMC5464546 | biostudies-other
| S-EPMC7424227 | biostudies-literature
| S-EPMC5790598 | biostudies-literature
| S-EPMC5807037 | biostudies-literature
| S-EPMC5865448 | biostudies-literature
| S-EPMC7437317 | biostudies-literature